UroGen Pharma Ltd., a biotech company specializing in urothelial and specialty cancers, announced it will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026. The presentation will include a fireside chat and one-on-one investor meetings in Miami Beach, FL, with a webcast available on UroGen's website. UroGen is known for its proprietary RTGel sustained-release technology and has two approved products for treating urothelial cancers non-surgically. This event provides an opportunity for investors to learn about UroGen's progress and future plans in cancer treatment innovation.
Lululemon invested in Syntetica's $30 million Series A funding to support its innovative recycling of Nylon 6 and Nylon 6,6, materials difficult to separate and reuse in textile waste. This move aligns with growing industry demand for sustainable, co...
Ethereum futures long positions among top traders increased by over 3 percentage points across both USDT- and coin-margined markets, indicating a broad-based shift in short-term sentiment. This rise suggests heightened attention on ETH compared to ot...
NVIDIA announced that leading Japanese companies in robotics and manufacturing are adopting its Cosmos, Isaac, Metropolis, and Jetson platforms to accelerate AI-powered intelligent machines across industries. The new Cosmos 3 Edge model enables real-...
Oil prices are rising sharply due to renewed US naval blockades on Iranian shipping and increased tensions in the Strait of Hormuz, a critical oil transit route. Brent crude is holding above $85 and WTI above $80, with forecasts suggesting WTI could ...
The US government announced it will impose a new 25% tariff on Brazilian ethanol starting next Wednesday, accusing Brazil of unfair trade practices. This tariff excludes major Brazilian exports like oil, beef, coffee, and aircraft parts. The move fol...
